Global Neuromodulation Devices Market to Expand at 14.40% CAGR 2012-2018 Health Articles | August 22 Shaquem Griffin Womens Jersey , 2016 The global neuromodulation devices market is anticipated to expand at a strong CAGR of 14.40% from 2012 to 2018, rising from an estimated value of US$2.7 bn in 2011 to over US$7 bn by 2018. The neuromodulation devices market is oligopolistic in nature with the top four companies representing nearly 91% of the overall market, finds Transparency Market Research (TMR) in a new study. The key players in the global neuromodulation devices market are Boston Scientific, Cyberonics Chris Carson Womens Jersey , Medtronic, and St. Judes Medical. 聽There are high entry barriers for new players owing to high capital investment and stringent government regulations. “However, large companies can enter the neuromodulation devices market through mergers and by acquiring smaller companies,” says the author of the report. The most lucrative way for new vendors to enter the global neuromodulation devices market is through the ownership of groundbreaking and innovative technologies Russell Wilson Womens Jersey , as technological advancement is a major driving force for the market. 聽The neuromodulation devices market is oligopolistic in nature with the top four companies representing nearly 91% of the overall market, finds Transparency Market Research (TMR) in a new study. The key players in the global neuromodulation devices market are Boston Scientific, Cyberonics, Medtronic Authentic Ugo Amadi Jersey , and St. Judes Medical. There are high entry barriers for new players owing to high capital investment and stringent government regulations. “However, large companies can enter the neuromodulation devices market through mergers and by acquiring smaller companies,” says the author of the report. The most lucrative way for new vendors to enter the global neuromodulation devices market is through the ownership of groundbreaking and innovative technologies, as technological advancement is a major driving force for the market. External Funding for Clinical Studies to Augur Well for Sales of Neuromodulation Devices 聽The rising geriatric population Authentic Phil Haynes Jersey , especially in developed countries such as the U.S., Japan, and Germany are likely to produce notable growth opportunities for the global neuromodulation devices market. This is because of the fact that the aged people are more susceptible to neurological disorders such as Parkinson’s and Alzheimer’s. Neuromodulation devices have proven to be extremely effective in treating Parkinson’s and other chronic illnesses induced by old age. 聽The growth of the global neuromodulation devices market is backed by external funding to conduct clinical studies. Such initiatives pave the way for the development of technologically updated devices and also reduce the R&D costs pertaining to the development of new products. Moreover, a rise in the prevalence of chronic diseases common in all age groups Authentic Gary Jennings Jr. Jersey , such as migraine and epilepsy has fuelled the demand for neuromodulation devices. “Some of the neurological disorders such as migraine have unmet medical needs, which gives a further push to the growth of the global neuromodulation devices market,” says a TMR analyst. 聽The minimally invasive characteristic of neuromodulation devices has helped the global neuromodulation devices market tread along a promising growth path. The increasing demand for minimally invasive surgeries can be attributed to fast recovery time and scar-less treatment. 聽Some other factors playing a crucial role in the growth of the global neuromodulation devices market are increasing healthcare related consumer expenditure, add-on therapy nature of neuromodulation devices Authentic Cody Barton Jersey , and technological advancements that ensure promising treatment options. 聽Side effects Associated with Neuromodulation Devices to Discourage Adoption Amongst Patients 聽Neuromodulation devices are planted through a surgery, which can have side effects on the body such as allergy or hoarseness. Neuromodulation devices also carry the risk of damaging the surrounding nerves and blood vessels owing to the electrical impulses generated by them. These factors tend to withdraw the interest of the patients in the neuromodulation devices implantation, thereby impeding the growth of the global neuromodulation devices market. In such a case, the availability of alternate treatment procedures such as drugs and other surgeries (e.g. Pallidotomy) hampers the growth of the global neuromodulation devices market. The neuromodulation devices have to undergo several rigorous clinical trials prior to their approval and availability in the market. This procedure increases the development cost of neuromodulation devices and challenges the vendors operating in the global neuromodulation devices market Authentic D.K. Metcalf Jersey , thereby discouraging the growth of the market. Also, the rapidly changing technologies pose a threat to the growth of the market. This trend makes the market volatile and acts as a high impact restraining factor for the market as technologies get outdated and redundant at a great pace. However, the increasing instances of outsourcing the manufacturing of neuromodulation devices are likely to curtail development costs while focusing on the development of safer technologies. 聽North America Market Shares to Show Downward Slide Owing to Lag in FDA Approval Process 聽The global neuromodulation devices market was valued at US$3.155 bn in 2012 and is anticipated to rise to US$7.072 bn in 2018, progressing at a CAGR of 14.4% from 2013 to 2018. In terms of geography Authentic Marquise Blair Jersey , North America was the leading segment by revenue in 2013 and is anticipated to lead the market by the end of 2018 with a dominant share of 60% in the global neuromodulation devices market. However, the regional segment is expected to